Live Breaking News & Updates on Compugen Systems|Page 6

Stay updated with breaking news from Compugen systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Partners: Intel's AI Efforts Could Get Boost From Kimrey's New Sales Group

Top Intel channel and distribution partners told CRN that the chipmaker’s new North America commercial and partner sales group could benefit its ‘AI everywhere’ strategy. ....

United States , Xeon Cpus , Kent Tibbils , Gary Palenbaum , Bob Olwig , Jason Kimrey , Harry Zarek , Megan Amdahl , Group Is Great Timing , World Wide Technology , Insight Enterprises , Technology Center , Hp Inc , Right Person To Lead New Group , North America , Xeon Scalable , Advanced Vector Extensions , Advanced Matrix Extensions , Advanced Technology , World Wide , Great Timing For Intel , Ontario Based Compugen , Core Ultra , Dell Technologies , Eyes And Ear For Commercial , High Say Do Ratio For Partner ,

Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer

Compugen Ltd. (NASDAQ: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced the appointment of Michelle Mahler, M.D., as Chief Medical Officer, effective March 1, 2024. Michelle will succeed Henry Adewoye, M.D., who is leaving Compugen to pursue other opportunities effective February 29, 2024, after 6 years with Compugen. ....

South Africa , Tel Aviv , Memorial Sloan Kettering Cancer Center , New York , United States , New York Presbyterian Hospital , San Francisco , Yvonne Naughton , Weill Cornell , Momenta Pharmaceuticals Inc , Corporate Communications , Therapeutics Inc , Stock Exchange , Clinical Development , Gilead Sciences , University Of The Witwatersrand , Compugen Ltd , Mount Sinai Medical Center , Aummune Therapeutics Ltd , Chief Medical Officer , Anat Cohen Dayag , Chief Executive Officer , Vice President , Momenta Pharmaceuticals , New York Presbyterian , Columbia Presbyterian ,

Checkpoint Inhibitors Clinical Trial Pipeline Insights | 180+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |

Checkpoint Inhibitors Clinical Trial Pipeline Insights | 180+ Key Companies Investigating Their Lead Candidates to Improve the Treatment Space |
medgadget.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medgadget.com Daily Mail and Mail on Sunday newspapers.

Sandeep Joshi , Immuneonco Biopharma , Akeso Biopharma , Serono Merck , Lyvgen Biopharma , Mereo Biopharma , Theravance Biopharma , Eucure Biopharma , Bristol Myers Squibb , Innovent Biologics , Lepu Biopharma , Market Research , Boehringer Ingelheim , Canbas Co Ltd , Key Checkpoint Inhibitors Companies , Secarna Pharmaceuticals Gmbh Co , Seagen Inc , Phio Pharmaceuticals , Alpine Immune Sciences , Route Of Administration , Tracon Pharmaceuticals Inc , Key Companies , Bio Thera Solutions , Shanghai Henlius Biotech Inc , Healthcare Services , Enlivex Therapeutics Ltd ,

Gilead Sciences (GILD) Q4 2023 Earnings Call Transcript

GILD earnings call for the period ending December 31, 2023. ....

United States , Mike Yee Jefferies , Olivia Brayer Cantor Fitzgerald , Geoff Meacham , Jacquie Ross , Colin Bristow , Carter Gould , Tyler Van Buren , Michael Yee , Chris Schott , Olivia Brayer , Cindy Perettie , Andrew Dickinson , Brian Abrahams , Johanna Mercier , Merdad Parsey , Terence Flynn Morgan Stanley , Salveen Richter , America Merrill Lynch , Terence Flynn , Salveen Richter Goldman Sachs , Randy Dickinson , Morgan Stanley , American Society Of Hematology , Geoff Meacham Bank , Goldman Sachs ,

Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript

Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript February 6, 2024 Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. Thank you for attending the Four Quarter and Full Year 2023 Gilead Sciences Earning Conference […] ....

United States , Andrew Dickinson , Merdad Parsey , Assembly Biosciences , American Society Of Hematology , Cell Therapy , Global Safety Database , American Society , Asian Dating Sites Without Payment , Gay Dating Sites , Gilead Sciences , Hiv Prevention , Merdad Parsey , Fourth Quarter ,